0000899243-18-027217.txt : 20181022
0000899243-18-027217.hdr.sgml : 20181022
20181022211555
ACCESSION NUMBER: 0000899243-18-027217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181018
FILED AS OF DATE: 20181022
DATE AS OF CHANGE: 20181022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chereau Frederic
CENTRAL INDEX KEY: 0001640592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38707
FILM NUMBER: 181133147
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001664106
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 471514975
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 61(0)428-338-594
MAIL ADDRESS:
STREET 1: 700 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-18
0
0001664106
LogicBio Therapeutics, Inc.
LOGC
0001640592
Chereau Frederic
C/O LOGICBIO THERAPEUTICS, INC.
610 MAIN STREET, 3RD FLOOR
CAMBRIDGE
MA
02139
1
1
0
0
President, CEO
Employee Stock Option (right to buy)
10.00
2018-10-18
4
A
0
212525
0.00
A
2028-10-17
Common Stock
212525
212525
D
The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018.
/s/ Matthias Jaffe, as Attorney-in-Fact
2018-10-22